GLP-1 Market
LLY $1183.46 ▲ +0.1% NVO $38.80 ▲ +0.5% PFE $28.67 ▲ +0.9% VKTX $35.56 ▼ -3.2% KLRA $11.21 ▼ -6.4% GPCR $35.93 ▼ -0.2% RHHBY $54.41 ▼ -0.7%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

JMT206

JMT206

Company
Shanghai JMT-Bio Inc.
Mechanism
Mechanism not yet reported
Route
Injectable
Recruiting trials
1 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

1 recruiting study currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 26, 2026

Find a Clinical Trial Near Me

See recruiting studies for JMT206 and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT07419698

    Evaluate the Safety, Tolerability, PK, and PD of JMT206 Injection in Healthy Participants

    Not yet reported Shanghai JMT-Bio Inc. 44 participants Est. completion 2026-11-01 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Not yet recruiting NCT NCT07840729

    Evaluate the Safety and Tolerability of Multiple Doses of JMT206 Injection in Obese Participants

    Not yet reported Shanghai JMT-Bio Inc. 90 participants Est. completion 2027-04-30 1 site Mixed
    Other conditions: Valid MeSH Conditiongs
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: JMT206, JMT206 injection

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.